Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Guided ADHD Therapy for Managing the Extent and Severity of Symptoms - A Randomized, Controlled, Parallel-group, Intervention Study to Assess an At-home, Game-based Digital Therapy for Treating Adult Patients With Attention-Deficit/Hyperactivity Disorder

NCT05296473 is registered in ClinicalTrials.gov with Lumos Labs, Inc. as lead sponsor.

NCT NCT05296473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05296473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Guided ADHD Therapy for Managing the Extent and Severity of Symptoms - A Randomized, Controlled, Parallel-group, Intervention Study to Assess an At-home, Game-based Digital Therapy for Treating Adult Patients With Attention-Deficit/Hyperactivity Disorder
Lead sponsor
Lumos Labs, Inc.
Phase
Not applicable
Overall status
Completed
Start date
May 5, 2022
Completion date
March 12, 2024
Enrollment
560 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

adhd